2348 — Dawnrays Pharmaceutical (Holdings) Income Statement
0.000.00%
Last trade - 00:00- HK$1.80bn
- HK$780.75m
- CNY1.15bn
- 85
- 92
- 74
- 98
Annual income statement for Dawnrays Pharmaceutical (Holdings), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 950 | 1,024 | 1,165 | 1,278 | 1,151 |
| Cost of Revenue | |||||
| Gross Profit | 536 | 551 | 675 | 767 | 642 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 619 | 669 | 679 | 777 | 695 |
| Operating Profit | 331 | 355 | 486 | 501 | 456 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 314 | 331 | 439 | 438 | 414 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 255 | 265 | 354 | 356 | 323 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 255 | 268 | 358 | 358 | 326 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 255 | 268 | 358 | 358 | 326 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.166 | 0.175 | 0.201 | 0.217 | 0.145 |
| Dividends per Share | |||||
| Special Dividends per Share |